NCT00568490View on ClinicalTrials.gov

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 1998

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Head and Neck CancerLung CancerLip CancerLip NeoplasmsHead and Neck Cancers
Interventions
PROCEDURE

Tumor biopsy

For patients who undergo tumor biopsy or resection at Stanford, approximately 500 mg of the tumor will be removed from the resection specimen

PROCEDURE

Phlebotomy

Blood draw (approximately 20 cc) prior to any anticancer therapy Weekly blood draw (approximately 20cc) only for patients who are undergoing radiation treatment at Stanford University

Trial Locations (1)

94305

RECRUITING

Stanford University School of Medicine, Stanford

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Dental and Craniofacial Research (NIDCR)

NIH

lead

Stanford University

OTHER